title: [Hypoprotidemia may explain imatinib intoxication in a patient with Philadelphia-positive acute lymphoblastic leukemia].
authors.forename: Emna
authors.initials: E
authors.lastname: Gaïes
authors.forename: Sameh
authors.initials: S
authors.lastname: Trabelsi
authors.forename: Rim
authors.initials: R
authors.lastname: Sahnoun
authors.forename: Issam
authors.initials: I
authors.lastname: Salouage
authors.forename: Nadia
authors.initials: N
authors.lastname: Jebabli
authors.forename: Rim
authors.initials: R
authors.lastname: Charfi
authors.forename: Mohamed
authors.initials: M
authors.lastname: Lakhal
authors.forename: Sonia
authors.initials: S
authors.lastname: Hdiji
authors.forename: Anis
authors.initials: A
authors.lastname: Klouz
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001549:Benzamides / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D006801:Humans; D007019:Hypoproteinemia / Q000139:chemically induced*; D000068877:Imatinib Mesylate; D008297:Male; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate